| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |